newscontact us

CESCA THERAPEUTICS APPOINTS DR. JOSEPH THOMIS TO ITS BOARD OF DIRECTORS

Rancho Cordova, CA, January 17, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapeutics, today announced that Dr. Joseph Thomis will join the Company’s Board of Directors…(more)